
Home Page
JOURNALS
Alcoholism:
Clinical & Experimental Research
Drug
& Alcohol Dependence
Alcohol
&
Alcoholism
Alcohol
Journal
of Studies on Alcohol
American
Journal of Drug & Alcohol Abuse
British
Medical
Journal
American
Journal of Epidemiology
International
Journal of Epidemiology
Journal
of Epidemiology & Community Health
About us
|
A
free service of
Life
Sciences
Editorial Services ─>
Drug
and Alcohol Dependence
Volume 80, Number 1,
October 2005
(Updated 11/26/2005)
Home Page
Ty A. Ridenour, Mildred Maldonado-Molina, Wilson M. Compton, Edward L.
Spitznagel, and Linda B. Cottler. Factors
associated with the transition from abuse to dependence among substance
abusers: Implications for a measure of addictive liability.
Drug and
Alcohol Dependence
80(1):1-14,
October 2005.
Address correspondence to Ty A. Ridenour,
Pennsylvania State
University, Prevention Research Center, 135 East Nittany Avenue, Suite
402, State College, PA 16801, USA. Tel: 814-865-4122; Fax:
814-865-6004.
Summary:
The objective was to test the validity of a potential measure for
bridging research on the addictive liability of drugs and research on
individual addiction liability. It was hypothesized that shorter length
of time between abuse onset and dependence (LOTAD) is
an indicator of greater addictive liability. Hypotheses were based on
animal studies and human studies. Retrospective data from the Diagnostic and Statistical Manual of
Mental Disorders, Fourth Edition (DSM-IV)
Substance Use Disorders Work Group were reanalyzed using configural
frequency analysis, survival curves, bivariate Kendall's tau
associations, and linear regression. Participants in the study were
recruited from community and clinical settings. The
measure was the Composite
International Diagnostic Interview–Substance
Abuse Module (CIDI–SAM). The shortest LOTADs were observed for
disorders related to use of cocaine and opiates, followed by cannabis,
then ethanol, regardless of the subsample that was analyzed. As
hypothesized, females and early initiators of drug use had shorter
LOTADs compared to men and other initiators of drug use; no consistent
differences in LOTAD were observed between African-Americans and
Caucasians. None of the LOTAD variance associated with differences
between drugs could be accounted for by gender, early use of the drug,
or ethnicity. Specific areas of research where LOTAD might be useful
and ways it might be improved are discussed.
NIAAA
Glossary Terms:
addiction, AOD dependence, AOD abuse, validation study,
individual as study subject, hypothesis testing,
disease onset, early AOD onset, diagnosis, diagnostic criteria,
disease course, statistical
estimation, regression analysis, cocaine, opiates, marijuana in any
form, alcoholic beverage, gender differences,
ethnic differences, racial differences, human study
|
Cuneyt Evren and Bilge Evren. Self-mutilation
in substance-dependent patients and relationship with childhood abuse
and neglect, alexithymia and temperament and character dimensions of
personality. Drug
and Alcohol Dependence 80(1):15-22,
October 2005.
Address correspondence to Cuneyt Evren,
AMATEM, Bakirkoy State
Hospital for Psychiatric and Neurological Disorders, 34747 Bakirkoy,
Istanbul, Turkey.
|
Summary:
The authors evaluated the prevalence of
self-mutilation
in Turkish male substance-dependent patients and investigated
the relationship of self-mutilation with childhood abuse and neglect,
alexithymia,
and temperament and character dimensions of personality. Consecutively
admitted males with substance dependence (N = 136; 96
alcohol and 40 drug) participated. Substance dependence was diagnosed
with
the Structured Clinical Interview (SCID-I) for
the Diagnostic and Statistical
Manual of Mental Disorders, Fourth Edition (DSM-IV), Turkish
version.
Patients were investigated with the Childhood
Abuse and Neglect Questionnaire, Toronto Alexithymia Scale
(TAS-20), and Temperament and
Character Inventory (TCI). Among
substance-dependent patients 34.6% were considered to be
self-mutilators.
Rates of being single and unemployed, histories of physical and sexual
abuse, and suicide attempts were higher in the self-mutilation group.
Current age,
age at first substance use, and age at regular substance use were lower
in the self-mutilation group. Mean of TAS-20 and "Difficulty in
Identifying Feelings" (DIF) and "Difficulty in Describing Feelings"
(DDF) subscales
of TAS-20 were higher in the self-mutilation group.
No significant
differences were found between groups in terms of TCI subscales. Age,
childhood
physical abuse, and suicide attempt history predicted self-mutilation
in logistic
regression. Young substance users with
childhood physical abuse histories could be the target population to
prevent self-mutilating behavior. The findings also suggests that
whenever self-mutilating behavior is present, the possibility of
childhood abuse, alexithymia, and suicide attempts must be evaluated.
NIAAA
Glossary Terms:
prevalence,
self-destructive behavior, Turkey, AOD abuse, AOD dependence, abused as
child, alexithymia,
personality trait,
variable, characteristic, factor,
marital status,
employment status, unemployed,
patient history, sexual abuse,
physical abuse, victim of abuse, suicidal behavior, age of AODU onset,
AOD use pattern, regression analysis, human study
|
Joan S. Tucker, Elizabeth J. D’Amico, Suzanne L. Wenzel, Daniela
Golinelli, Marc N. Elliott, and Stephanie Williamson. A
prospective study of risk and protective factors for substance use
among impoverished women living in temporary shelter settings in Los
Angeles County. Drug and Alcohol Dependence 80(1):35-43, October 2005.
Address correspondence to RAND Corporation,
Health, 1776 Main
Street, PO Box 2138, Santa Monica, CA 90407-2138, USA. Tel:
310-393-0411 x7519; Fax: 310-260-8159.
Summary:
Few prospective studies have examined risk and
protective factors for substance use among homeless women, although
alcohol and drug use are significant problems in this population. This
6-month
prospective study identified psychosocial, behavioral, and economic
predictors of drinking to intoxication, crack cocaine use, and
marijuana use in
a probability sample of women (N
= 402) living in temporary shelters
in Los Angeles County, California. Sexual risk
behavior and depressive symptoms were risk factors for more
frequent intoxication, marijuana use, and crack use. Drinking to
intoxication was additionally predicted by perceived human
immunodeficiency virus (HIV), lower social support, more
avoidant and less active
coping, and lower self-esteem. Additional predictors of marijuana use
included partner alcohol misuse and less social support, whereas more
frequent crack use was additionally predicted by partner alcohol
misuse, lack of economic resources, and more avoidant and less active
coping. The findings suggest that effective substance use programs
may need an integrative approach that addresses other types of risk
behaviors, assists women in strengthening their support networks and
learning effective coping skills, and provides access to basic services
such as housing and health care. For women in relationships, there may
be
a further need to address issues of partner substance use.
NIAAA
Glossary Terms:
homeless, homelessness, female,
alcoholic beverage, AOD use for intoxication, predictive factor, risk
factors,
psychosocial environment, behavior,
economic aspects of AOD and AOD use, human immunodeficiency virus,
disease susceptibility,
social support, emotional and psychiatric depression, coping,
loss of self-esteem, crack cocaine, marijuana in any form, poverty,
coping skills,
housing,
health care availability and access, spouse or significant other, human
study
|
Miriam Bottlender and Michael Soyka. Outpatient
alcoholism treatment: Predictors of outcome after 3 years.
Drug and
Alcohol Dependence
80(1):83-89,
October 2005.
Address correspondence to Miriam Bottlender,
Department of
Psychiatry, Ludwig-Maximilians University, Munich, Nussbaumstr. 7,
80336 Munich, Germany. Tel: +49-89-5160-2777; Fax:
+49-89-5160-5748.
|
Summary:
Predictors of
relapse after completion of an intensive outpatient treatment program
for
alcoholism were investigated in a 3-year prospective study of
consecutively recruited participants (N = 103). Since
previous studies mainly revealed
that alcohol dependence severity and comorbid psychopathology were
predictive of subsequent relapses, the impact of these and other
pre-treatment variables on the 36-month outcome was evaluated using
logistic regression analysis. Variables were assessed using a
structured interview. Patients were personally interviewed at entry to,
and
the end of, an outpatient treatment program and 6, 12, 24, and 36
months after treatment completion. The treatment program was completed
by 74 patients. At the 36-month follow-up, 2 patients had died (after
heavy alcohol relapse) and 88 (88%)
of the remaining patients were located and personally
re-interviewed. Forty-four (43%) patients were abstinent, 46 (45%) had
relapsed, and 12 (12%) were classified as improved for the total
follow-up period. Logistic regression analysis revealed that
significant predictors of relapse were treatment drop-outs, female
sex, and sum of positive life events prior to treatment (relapsers had
significantly fewer positive life events). In
contrast to previous studies, this study could not confirm the
importance of
risk factors for relapse such as dependence severity. Treatment
drop-out was the strongest predictor for post-treatment relapse. Since
women were at an increased risk for relapse,
gender-specific treatment approaches should be considered. In summary,
the effectiveness of this intensive outpatient treatment
program is favorable, although selection criteria of must be
taken into account.
NIAAA
Glossary Terms: AODD
relapse, predictive factor, AOD dependence, disease severity,
comorbidity, predictive factors, risk factors, evaluation study,
regression analysis, outpatient care, treatment outcome, follow-up
study, interview,
program dropout, gender differences,
life circumstances, life events, human study
|
Andrew Rosenblum, Stephen Magura, Deborah J. Kayman, and Chunki
Fong. Motivationally
enhanced group counseling for substance users in a soup kitchen: A
randomized clinical trial. Drug and Alcohol Dependence 80(1):91-103, October 2005.
Address correspondence to Andrew Rosenblum,
National Development
and Research Institutes, Inc., 71 West 23rd Street, 8th Floor, New
York, NY 10010, USA. Tel: 212-845-4528; Fax: 917-438-0894.
Summary:
Soup
kitchens tend to serve residentially unstable adults with a high
prevalence of substance abuse. In this study, soup
kitchen guests (N = 289) who
reported drug or alcohol problems were randomly
assigned to information and referral (I&R) plus peer advocacy
(peers encouraging subjects to participate in other services) (n
= 139)
or to an experimental 12-session motivational group (three sessions a
week for 4 weeks) followed by a 36-session cognitive-behavioral group
(three sessions a week for 12 weeks), plus I&R and peer advocacy.
The mean age was 42; 82% were male; 68% were African-American; 81% had
unstable
residence; and 14% were positive for human immunodeficiency virus.
Intervention subjects were significantly more likely than
controls to have increased their participation in some type of
substance abuse intervention during follow-up and were also
significantly more likely than controls to have
reduced both drinking and heavy drinking at follow-up (the groups did
not differ in reduction of cocaine use). Interaction
analysis indicated that the experimental intervention was more
effective for participants with higher rather than lower substance
abuse severity at baseline. The results support the concept that
motivationally enhanced group counseling, provided as a low-threshold
outreach intervention, can help increase participation in formal
treatment and 12-step groups and reduce substance abuse,
particularly for those starting with high severity of use.
NIAAA
Glossary Terms: AOD
abuse, homelessness, group therapy,
peer counseling,
advocacy,
intervention referral,
motivation, HIV infection, controlled study, follow-up study, treatment
outcome, AOD intake per occasion, AOD consumption, heavy AOD use,
disease severity, human study
|
Frederick S. Stinson, Bridget F. Grant, Deborah A. Dawson, W. June
Ruan, Boji Huang, and Tulshi Saha. Comorbidity
between DSM-IV alcohol and specific drug use disorders in the United
States: Results from the National Epidemiologic Survey on Alcohol and
Related Conditions. Drug and Alcohol Dependence 80(1):105-116, October 2005.
Address correspondence to Frederick S.
Stinson, Laboratory of
Epidemiology and Biometry, Room 3075, Division of
Intramural Clinical and Biological Research, National Institute on
Alcohol Abuse and Alcoholism, National Institutes of Health, M.S. 9304,
5635 Fishers Lane, Bethesda, MD 20892-9304, USA. Tel: 301-443-4898;
Fax: 301-443-1400.
|
Summary:
This study investigated the
prevalence and comorbidity of alcohol and specific drug use disorders
and identified sociodemographic and psychopathologic correlates and
treatment seeking among three groups of respondents: those with
alcohol use disorders only, those with drug use disorders only, and
those with comorbid alcohol and drug use disorders. Information
on 12-month alcohol and specific drug use disorders in the United
States was obtained in personal interviews in the National
Institute on Alcohol Abuse and Alcoholism's (NIAAA) 2001–2002 National
Epidemiologic Survey on Alcohol and Related Conditions (NESARC: N = 43,093).
Prevalences
were: alcohol use disorder only, 7.35%; drug use disorder only, 0.90%;
and comorbid alcohol and drug use disorder, 1,10%. of these The
three groups differed in sociodemographic and
psychopathologic correlates, with the drug use disorder
and comorbid groups
significantly more likely to be young, male, never married, and of
lower
socioeconomic status than the alcohol use disorder only group.
Associations between current alcohol use disorders and 25 specific drug
use disorders were generally positive and statistically significant.
The 12-month prevalence of treatment seeking significantly increased
from 6.06% for those with an alcohol use disorder only, to 15.63% for
those with a drug use disorder only, and to 21.76% for those with
comorbid alcohol and drug use disorders. The
study provides detailed data on the homotypic comorbidity of alcohol
use disorders and 25 different drug use disorders and confirms the high
levels of association seen in previous studies based on lifetime
measures. Implications are discussed in terms of
integrating alcohol and drug treatment services and refining prevention
and intervention efforts.
NIAAA
Glossary Terms:
prevalence, comorbidity, AOD abuse, AOD dependence,
alcohol use disorder classification, interview, survey, demographic
characteristics, psychopathology, statistical association,
help-seeking behavior,
co-treatment,
AOD prevention, intervention (persuasion to treatment), human study
|
Deborah S. Hasin, Mark Hatzenbueler, Sharon Smith, and Bridget F.
Grant. Co-occurring
DSM-IV drug abuse in DSM-IV drug dependence: Results from the National
Epidemiologic Survey on Alcohol and Related Conditions.
Drug and Alcohol
Dependence 80(1):117-123,
October 2005.
Address correspondence to Bridget F. Grant,
Laboratory of
Epidemiology and Biometry, Room 3077, Division of
Clinical and Biological Intramural Research, National Institute on
Alcohol Abuse and Alcoholism, National Institutes of Health, M.S. 9304,
5635 Fishers Lane, Bethesda, MD 20893-7003, USA. Tel:
301-443-7370; fax: 301-443-1400.
Summary:
A potential exists for underestimation and biased estimates in
surveys that rely on abuse as a screening method for drug dependence,
making it important to determine the extent to which dependence
occurs with or without abuse. This study estimated the prevalence of
DSM-IV (Diagnostic and Statistical
Manual of Mental Disorders, Fourth Edition) drug dependence with
and without drug
abuse in a nationally representative sample, as well as in subgroups
defined by sex, age, and race or ethnicity. Among all drug-dependent
respondents, 22.0% (19.5% of males and 27.8% of females)
did not additionally meet criteria for
abuse. Current drug
dependence without abuse was especially common among females aged 45–64
years (52.6% of all cases). Among those with lifetime diagnoses of drug
dependence, a small proportion overall, 5.0% had no symptoms of abuse,
with the highest proportion again found among females 45–64 years old
(19.5%
of all cases). It was concluded that choosing drug abuse as a
screening method for drug
dependence in large epidemiologic studies will differentially
underestimate the prevalence of dependence by subgroup, affecting many
types of research. Dependence with and without abuse may represent
heterogeneous phenotypes for genetic and gene-environment research,
which should be explored.
NIAAA
Glossary Terms: AOD
abuse, AOD dependence,
AODR behavioral markers,
identification and screening for AODD, diagnostic criteria, gender
differences, prevalence, statistical estimation, epidemiology,
epidemiological indicators, phenotype, genetic trait,
gene-environment interaction,
research issue, human
study
|
Home Page
Drug
and Alcohol Dependence
Volume
79, Number 3, September 2005
(Updated 10/21/2005)
Home Page
Héctor
M. Manrique, Marta Miquel, and Carlos M.G. Aragon. Brain
catalase mediates potentiation of social recognition memory produced by
ethanol in mice. Drug and Alcohol Dependence 79(3):343-350, September 2005.
Address correspondence to Carlos M.G. Aragon,
Area de
Psicobiologia, Universitat Jaume I, Campus de Riu Sec, 12071
Castelló, Spain. Tel.: +34 964 729835; fax: +34 964 729267,
e-mail: aragon@psb.uji.es.
Summary:
This
study used the social recognition test (SRT) to evaluate ethanol's
effects on memory and the mediating role of catalase. In the SRT, the
reduction in investigation time of
a juvenile of the same species, when this social stimulus is presented
for the
second time, is considered a reliable index of memory. The recognition
capacity of mice was evaluated by calculating exploration
ratios (ER). Ethanol (0.0, 0.5, 1.0, or 1.5 g/kg) was administered
intraperitoneally immediately after the first juvenile presentation,
and 2 hours later
the
juvenile was re-exposed to the adult. Additionally, adult mice received
the catalase inhibitor aminotriazole (AT) 5 hours before juvenile
presentation or sodium azide
30 minutes before juvenile presentation. Ethanol (1.0
and
1.5 g/kg) reduced ER, indicating improved
memory. The improvement was prevented by pretreatment with either AT or
sodium azide. Neither AT nor sodium azide attenuated the
memory-enhancing capacity of N-methyl-D- aspartate or
nicotine, which suggests a specific
interaction between catalase inhibitors and ethanol in their effects on
memory. These results suggest that brain catalase activity can
mediate the memory-enhancing capacity of ethanol and add further
support to the idea that this enzyme mediates some of ethanol's
psychopharmacological effects.
NIAAA
Glossary Terms:
ethanol,
intraperitoneal
administration, memory, catalase, enzyme inhibitors,
azide,
N methyl D aspartate, nicotine, brain, laboratory mice, animal study
|
G. Bischof, S. Reinhardt, J. Grothuesa, I. Dybek, C. Meyer, U. Hapke,
U. John, and H.-J. Rumpf. Effects of
item sequence on the performance of the AUDIT in general practices.
Drug and
Alcohol Dependence 79(3):373-377,
September 2005.
Address correspondence to G. Bischof,
Department of Psychiatry
and Psychotherapy, Research Group Substance Abuse: Treatment,
Epidemiology and Prevention (S:TEP), University of Luebeck, Ratzeburger
Allee 160, 23538 Luebeck, Germany. Tel.: +49 451 500 4860; fax: +49 451
500 3480, e-mail: gallus.bischof@ukl.uni-luebeck.de.
Summary:
The effects of item sequence on the performance of the Alcohol Use Disorders Identification Test
(AUDIT) in general practices were evaluated by comparing two randomly
applied versions of the AUDIT
with different item sequence. The participants were recruited from
general practices in two northern
German cities and divided into two groups. One
group received the original version of the AUDIT, which starts with
three items
addressing frequency and quantity of alcohol use (AUDIT1). The other
group received a version of the AUDIT in which these items were put at
the end of
the questionnaire (AUDIT2). In total, 10.803 screenings were conducted
(refusal rate: 5%). Alcohol use disorders were diagnosed using the Munich-Composite International Diagnostic
Interview (M-CIDI). Logistic
regression analysis revealed that AUDIT1 subjects had higher
scores in the consumption items of the AUDIT, whereas AUDIT2 subjects
scored higher on items focusing on symptoms of alcohol dependence or
abuse. Thus the sequence of AUDIT items does influence the
report of drinking patterns and symptoms of alcohol use disorders in
general practice patients.
NIAAA
Glossary Terms:
alcohol use test, questionnaire, evaluation study, comparative study,
AOD use frequency, AOD consumption, AOD intake per occasion, AOD abuse,
symptom, regression analysis,
alcohol use disorder classification,
primary health care,
general practitioner, human
study
|
Bradley T. Conner, Ernest P. Noble, Steven M. Berman, Tulin Ozkaragoz,
Terry Ritchie, Tim Antolin, and Courtney Sheen. DRD2
genotypes and substance use in adolescent children of alcoholics.
Drug and
Alcohol Dependence 79(3):379-387,
September 2005.
Address correspondence to Ernest P. Noble,
Department of
Psychiatry and Biobehavioral Sciences, University of California, Los
Angeles, Los Angeles, CA 90024, USA. Tel.: +1 310 825 1891; fax:
+1 310 206 7309, e-mail: epnoble@ucla.edu.
Summary:
Children of alcoholics (COAs) are a population
at increased risk for developing substance use problems. Genetic
studies support the A1 allele of the D2 dopamine receptor gene (DRD2)
as a marker of risk for alcoholism and substance use disorders. This
study assessed substance use in adolescent sons of alcoholics
(N = 48) with the DRDR A1+
allele (A1A1/A1A2 genotypes) or the A1− allele (A2A2 genotype). The
results showed that boys with the A1+
allele tried (p = 0.0001) and got intoxicated on
alcohol more often (p = 0.009)
than boys with the A1− allele. A1+ allele tried more (p = 0.004)
and used more substances overall (p = 0.008) than boys
with the A1− allele. Boys with the A1+ allele
became habitual tobacco users more often (p = 0.03)
and
experienced marijuana high at an earlier age (p = 0.001)
than boys with the A1− allele. The best predictors of
substance use severity in boys with the A1+ allele were
Psychoticism (p = 0.01) and Negative Affect (p = 0.04).
The results support the DRD2 A1 allele as a marker
identifying a subgroup of COAs at high risk for developing substance
use problems.
NIAAA
Glossary Terms:
children of alcoholics,
AOD effects and AODR problems, familial alcoholism,
risk factors,
predictive factor, AOD intoxication, multiple drug use, tobacco in any
form, problem severity, dopaminergic receptors, allele,
genetic markers, genotype, adolescent, male,
mood and affect disturbance, human study
|
Evelien A.P. Poelen, Ron H.J. Scholte, Rutger C.M.E. Engels, Dorret I.
Boomsma, and Gonneke Willemsen. Prevalence
and trends of alcohol use and misuse among adolescents and young adults
in the Netherlands from 1993 to 2000. Drug and Alcohol Dependence79(3):413-421, September 2005.
Address correspondence to Evelien A.P. Poelen,
Behavioural
Science Institute, Radboud University Nijmegen, P.O. Box 9104, 6500 HE
Nijmegen, The Netherlands. Tel.: +31 24 361 57 67; fax: +31 24
361 27 76; e-mail: e.poelen@pwo.ru.nl.
Summary:
An overview of Dutch studies on the prevalence of alcohol
use is presented, with added findings from the authors' own study on
the prevalence of drinking
among adolescents and young adults aged 12–30 years in the Netherlands.
Data were collected as part of a longitudinal study by the Netherlands
Twin Register in 1993 (n =
3,885), 1995 (n = 4,814), 1997
(n = 3,772), and
2000 (n = 4,090). Lifetime
alcohol use, drinking frequency, drinking quantity, lifetime
drunkenness, frequency of
drunkenness, and problem drinking were measured. The main findings
were: (1) alcohol
use increased with age until age 25 years, then decreased;
(2) males exceeded females on all aspects of alcohol use, except for
the youngest age group and lifetime alcohol use; (3) time
trends indicated an increase in frequency and quantity of drinking
among 12–15-year-old adolescents during the 1990s; and (4)
21–25-year-old females drank more frequently, consumed more drinks a
week, had more experience with lifetime drunkenness, and were
intoxicated more
often in 2000 than in 1993. Among 21–25-year-old males, there was an
increase of
drunkenness and problem drinking during the 1990s.
NIAAA
Glossary Terms:
underage drinking, adolescent, young adult, prevalence, Netherlands,
AOD use, AOD use frequency, AOD consumption, AOD intake per occasion,
AOD intoxication, AOD
effects and AODR problems, gender differences, trend,
human study
|
Home Page
Drug
and Alcohol Dependence
Volume
79, Number 2, August 2005
(Updated 8/27/2005)
Home Page
Hendree
E. Jones, Conrad J. Wong, Michelle Tuten, and Maxine L.
Stitzer. Reinforcement-based
therapy: 12-month evaluation of an outpatient drug-free treatment for
heroin abusers. Drug and Alcohol Dependence 79(2):119-128, August 2005.
Address correspondence to Hendree E. Jones,
Cornerstone
Treatment Research Clinic, Department of Psychiatry and
Behavioral Sciences, Johns Hopkins Bayview Medical Center, Cornerstone
D-3-E, 4940 Eastern Avenue, Baltimore, MD 21224, USA. hendreejones@yahoo.com
Summary:
A controlled study of opioid-dependent patients was carried out to
assess the efficacy of reinforcement-based therapy (RBT) in producing
enhanced abstinence outcomes. After a
brief residential detoxification and completion of medically managed
taper, patients were randomly assigned to RBT (n = 66)
or to usual care (n = 64) in community treatment programs.
The 6-month RBT program
offered an array of abstinence-based incentives including rent payment
for recovery housing, program-led recreational activities, and skills
training for getting employment. Compared to usual care, RBT produced
significantly higher
abstinence rates (self-reported and urinalysis-confirmed) from opioids
and cocaine at 1 month (42% versus 15%) and 3
months (38%
versus 17%) during treatment, but not at 6 or 12 months after
enrollment. The RBT group also showed significant
increases in the number of days worked and the amount of legal income
earned at 3, 6, and 12 months. The results suggest that an intensive
reinforcement-based therapy that includes
abstinence-based recovery housing is a promising approach, but
further research is needed to determine the role of treatment intensity
and the specific efficacy of RBT's components.
NIAAA
Glossary Terms: AOD dependence, reinforcement,
psychosocial treatment method, treatment outcome, AOD abstinence,
community-based treatment, controlled study, comparative study, self
report, urinalysis, opioids, opiates, cocaine, employment, income,
human study
|
Louisa Degenhardt, Elizabeth Conroy, Carolyn Day, Stuart Gilmour,
and Wayne Hall. The impact
of a reduction in drug supply on demand for and compliance with
treatment for drug dependence. Drug and Alcohol Dependence 79(2):129-135, August 2005.
Address correspondence to Louisa Degenhardt,
National Drug and
Alcohol Research Centre, University of New South Wales, Sydney, NSW
2052, Australia. l.degenhardt@unsw.edu.au
|
Summary:
In early 2001, Australia experienced a sudden,
dramatic and sustained decrease in heroin availability that was
accompanied by sharp increases in price and decreases in street level
purity. Because these unprecedented changes
occurred in a context of widespread treatment availability, this study
was able to examine, for the first time, the impact of a sharp
reduction in heroin supply in New South Wales (NSW) on entry to and
adherence with treatment for heroin dependence. Since there is evidence
of
drug substitution by some users, the study also examined the
effects of the shortage on entry to treatment for other forms of drug
dependence. Interrupted time-series analysis was used to examine
the number of persons entering opioid pharmacotherapy and other
treatment modalities in NSW for heroin dependence and for treatment of
other types of drug dependence. The heroin
shortage was associated with a reduction in the number of younger
persons entering opioid pharmacotherapy, the number of persons entering
heroin withdrawal or “assessment
only” treatment episodes decreased dramatically, and there appeared to
have been small improvements
in adherence to and retention in heroin treatment after the reduction
in heroin supply. Relatively small increases occurred in numbers
being treated for cocaine dependence. In the
context of good treatment provision, a reduction in heroin supply
appeared to produce modest improvements in intermediate outcomes.
Supply and demand reduction measures, when both are implemented
successfully, may be complementary.
NIAAA
Glossary Terms: heroin, opioids, opiates, AOD
dependence, AOD availability,
help-seeking behavior, treatment factors, treatment
method, treatment outcome, patient compliance,
patient retention, drug therapy, cocaine, human study
|
Jürgen Rehm, Ulrich Frick, Christina Hartwig, Felix Gutzwiller,
Patrick Gschwend, and Ambros Uchtenhagen. Mortality
in heroin-assisted treatment in Switzerland 1994–2000.
Drug and
Alcohol Dependence 79(2):137-143,
August 2005.
Address correspondence to Jürgen Rehm,
Addiction Research
Institute, Konradstr. 32, CH 8031 Zurich, Switzerland. jtrehm@aol.com
Summary:
Mortality of participants in heroin-assisted treatment
in Switzerland over a 7-year period (1994 to 2000) was assessed and
compared
to reported mortality in the general population and other populations
of
opioid users. Methods used included estimation of person-years under
heroin-assisted treatment based on
the complete case registry of heroin-assisted treatment in Switzerland,
and estimation of standardized mortality ratios comparing the
population in
treatment to the Swiss population (standardized to the year 2000). Over
the 7-year period, the crude death rate of patients in
heroin-assisted treatment, and including 1 month after discharge from
treatment, was 1% per year. The standardized mortality ratio (SMR) for
the
entire observation period was 9.7 (95% confidence interval [CI],
7.3–12.8), with females
having higher SMRs than males (17.2 versus 8.4). There was no clear
temporal trend. Mortality in heroin-assisted treatment was low compared
to
the estimated mortality of Swiss opioid users in the 1990s (2.5% to
3%). It was also low compared to mortality rates of opioid
users in other maintenance treatments in other countries as reported in
the literature. The SMR was also lower than that reported in the only
meta-analysis in the literature: 13.2 (95% CI, 12.3–14.1). The low
mortality rate is all the more noteworthy as heroin-assisted treatment
in Switzerland included only refractory opioid addicts with existing
severe somatic or mental problems.
NIAAA
Glossary Terms: mortality, heroin, AOD dependence,
addiction, treatment method, drug therapy, risk analysis, relative
risk, gender differences, human study
|
Douglas B. Marlowe, David S. Festinger, Karen L. Dugosh, and Patricia
A. Lee. Are
judicial status hearings a “key component” of drug court?
Drug and Alcohol Dependence 79(2):145-155, August 2005.
Address correspondence to Douglas B. Marlowe,
Treatment Research
Institute at the University of Pennsylvania School of Medicine, 600
Public Ledger Building, 150 South Independence Mall West, Philadelphia,
PA 19106-3475, USA. Marlowe@Tresearch.org
Summary:
The superiority of drug courts to traditional
probation programs for enhancing treatment retention and reducing
substance use and crime among drug offenders is supported by
substantial evidence. Few studies have isolated
the effects of the hypothesized critical components of drug courts to
determine their contributions to outcomes. This study assessed
outcomes at 6 and 12 months post-admission for misdemeanor drug court
clients who were randomly assigned to different dosages of judicial
status hearings. Although earlier work (Festinger, D.S. et al. Drug
and Alcohol Dependence 68:151–157, 2002) revealed superior
effects
during treatment for high-risk participants who were assigned to more
frequent bi-weekly
hearings, those effects did not extend beyond treatment. The results
did
reveal significant pre-to-post improvements for participants, as a
whole, in self-reported drug use, alcohol use, and criminal recidivism;
however, without a no-drug court control condition, it is not possible
to determine the magnitude of the drug court program's effect.
Approximately half of the participants resumed drug or alcohol use
within 12 months of admission to drug court, and approximately 10%–15%
resumed illegal activities. These findings lend credence to the
potential effectiveness of drug courts, but continuing-care
strategies are needed to extend the effects of drug courts beyond the
initial active phases of the program.
NIAAA
Glossary Terms:
drug court,
illicit drug, alcoholic beverage, AOD use, patient retention, crime,
treatment factors, treatment outcome,
randomized controlled trial, self report,
aftercare, human study |
Alison Oliveto, James Poling, Kevin A. Sevarino, Kishorchandra R.
Gonsai, Elinore F. McCance-Katz, Susan M. Stine, and Thomas R.
Kosten. Efficacy of
dose and contingency management procedures in LAAM-maintained
cocaine-dependent patients. Drug and Alcohol Dependence 79(2):157-165, August 2005.
Address correspondence to Alison Oliveto,
Department of
Psychiatry, Yale School of Medicine and the VA CT Healthcare System,
West Haven, CT, USA. olivetoalison@uams.edu
Summary:
A 12-week clinical trial was conducted to examine the efficacy of
maintenance drug dose and contingency management (CM) procedures in
opioid- and cocaine-dependent patients maintained on levo-alph-acetyl-methadol
(LAAM). Opioid-
and cocaine-dependent participants (N
= 140) were randomly assigned to
one of the following treatment conditions: LAAM (30,
30, 39
mg/MWF) with CM procedures (LC group); LAAM (30, 30,
39 mg/MWF) without CM (LY group); LAAM (100, 100, 130 mg/MWF) with CM
(HC group);
LAAM (100, 100, 130 mg/MWF) without CM (HY group). Urine samples were
collected three times a week. In CM, each urine negative for both
opioids
and cocaine resulted in a voucher worth a certain monetary value that
increased for consecutively drug-free urines. Subjects not assigned to
CM received vouchers according to a yoked schedule. Vouchers were
exchanged for mutually agreed upon goods and services. Groups generally
did not differ on retention and baseline characteristics. Overall
opioid use was lowest in the HC and HY groups; opioid use decreased
most
rapidly over time in the HC group relative to the HY, LC and LY groups.
Overall cocaine use was lowest in the HC group relative to the HY, LC,
and LY groups; cocaine use decreased over time most rapidly in the HC
and LY groups. Abstinence from both was greatest in the HC group.
Opioid withdrawal symptoms decreased fastest in the high-dose
groups relative to the low-dose groups. These results suggest that an
efficacious maintenance dose is necessary for contingencies to be
effective in facilitating both opioid and cocaine abstinence.
NIAAA
Glossary Terms: LAAM,
drug therapy, contingency management, treatment and maintenance, AOD
dependence, opioids, opiates, cocaine, urinalysis, comparative study,
AOD withdrawal syndrome, dose-response relationship, human study
|
Robert G. Carlson, Jichuan Wang, Russel S. Falck, and Harvey A.
Siegal. Drug use
practices among MDMA/ecstasy users in Ohio: a latent class analysis.
Drug and
Alcohol Dependence 79(2):167-179,
August 2005.
Address correspondence to Robert G. Carlson,
Center for
Interventions, Treatment and Addictions Research, Wright State
University School of Medicine, 143 Biological Sciences Building, 3640
Colonel Glenn Highway, Dayton, OH 45435, USA. robert.carlson@wright.edu
Summary:
This
study describes the drug use practices among recent users (N = 402) of
3,4-methelyenedioxymethamphetamine (MDMA; "ecstasy") recruited in
Ohio using
respondent-driven sampling. Of the participants, ~64% were men and
81.6% were white; the mean age was 20.9 years. Latent class
analysis was used to identify subgroups of MDMA users, with
classification based on use of cocaine,
opioids, amphetamines, tranquilizers, inhalants, marijuana, and
hallucinogens during the previous 6 months, and days of alcohol
intoxication
in the past 30. A three-class model was
preferable and reflected "Limited range" (Class 1), "Moderate range"
(Class 2), and "Wide
range" (Class 3) drug use patterns. For example, the conditional
probability of
using opioids during the previous 6 months was 0.07 in Class 1, 0.59 in
Class 2, and 0.88 in Class 3. Other substances followed similar
patterns. Predictors of class membership were examined in a multinomial
logit model in which Class 1 ("Limited range") was treated as the
reference group. Participants who were white, younger, and who reported
more than 10 occasions of MDMA use were more likely to be in the “Wide
range” drug use class (Class 3). Latent class analysis is a useful
method to help
describe and understand variability in multiple-drug use patterns.
NIAAA
Glossary Terms: MDMA, cocaine, opioids, opiates,
amphetamines,
tranquilizers,
inhaled substance, marijuana in any form,
hallucinogens, alcoholic beverage, multiple drug use, AOD intoxication,
AOD use pattern, predictive factor, comparative study, racial
differences, age differences, human study |
Melissa Tracy, Tinka Markham Piper, Danielle Ompad, Angela Bucciarelli,
Phillip O. Coffin, David Vlahov, and Sandro Galea. Circumstances
of witnessed drug overdose in New York City: implications for
intervention. Drug
and Alcohol Dependence 79(2):181-190,
August 2005.
Address correspondence to Sandro Galea, Center
for Urban
Epidemiologic Studies, New York Academy of Medicine, 1216 Fifth Avenue,
New York, NY 10029, USA. sgalea@nyam.org
Summary:
Drug
users frequently witness the nonfatal and fatal drug overdoses of their
peers, but often fail to intervene effectively to reduce morbidity and
mortality. This study assessed the circumstances of witnessed
heroin-related
overdoses in New York City among a predominantly minority
population of drug users. Heroin, crack, and cocaine users (N = 1,184) were
interviewed between Nov. 2001 and Feb. 2004. Witnessing at least one
nonfatal or fatal heroin-related overdose was reported by 672 (56.8%)
respondents. Of
those, 444 (67.7%) reported that they or someone else present called
for medical help for the overdose victim at the last witnessed
overdose. In multivariable models, the likelihood of calling for
medical help was associated with the respondent never having
experienced an
overdose personally and the witnessed overdose occurring in a public
place.
The most commonly cited reason for not
calling for help or delaying before doing so was fear of police
response (52.2%). Attempts to revive
the overdose victim through physical stimulation (e.g., applying ice,
causing pain) were reported by 59.7% of respondents, while first aid
measures were attempted in only 11.9% of events. Efforts to equip drug
users to manage overdoses effectively, including training in first aid
and the provision of naloxone, and the reduction of police involvement
at overdose events may have a substantial impact on overdose-related
morbidity and mortality.
NIAAA
Glossary Terms:
AOD overdose mortality, AOD poisoning, morbidity, heroin, crack cocaine, cocaine, interview, self
report, minority group,
multivariate analysis,
help-seeking behavior,
medically necessary care,
law enforcement worker, naloxone,
human study |
Anna Maria Bargagli, Patrizia Schifano, Marina Davoli, Fabrizio
Faggiano, Carlo A. Perucci, and The VEdeTTE Study Group. Determinants
of methadone treatment assignment among heroin addicts on first
admission to public treatment centres in Italy. Drug and Alcohol Dependence 79(2):191-199, August 2005.
Address correspondence to Anna Maria Bargagli,
Department of
Epidemiology, ASL Rome E, Via di S. Costanza 53, 00198 Rome,
Italy. bargagli@asplazio.it
Summary:
The aims were to identify factors associated with entering any
methadone treatment at
first admission at a treatment center in Italy and to investigate
determinants of receiving detoxification or maintenance methadone
treatments.
Data were analyzed from heroin addicts (N = 565) who entered for the
first time one of 90 National Health Service (NHS) treatment centers in
12 Italian regions
between September 1998 and March 2001. Subjects were interviewed at
admission by the center's staff and followed-up for 18 months. Details
on treatments provided were recorded using a standardized form. Random
effects logistic regression analysis was applied. Factors positively
associated with any methadone
treatment
assignment were being younger than 25 years and using heroin more than
twice a day, having been recently incarcerated, and living with a
partner. Independent predictors of admission to methadone maintenance
were injecting heroin, having sex without a condom in the previous 6
months, being human immunodeficiency virus-positive, and having been
enrolled at a NHS treatment center where a
psychiatrist was present. Using heroin once a day or more and using
cocaine were factors associated with enrolment into detoxification
treatment. A significant heterogeneity between centers was observed.
These results provide an insight into the different
profiles of patients who are enrolled in methadone treatments. The
observed
heterogeneity between centers indicates the need to develop and
implement common guidelines for the access of heroin addicts to
substitution treatment.
NIAAA
Glossary Terms: methadone, Italy,
treatment and maintenance, interview, follow-up study, regression
analysis, treatment factors, age differences, heroin, AOD use
frequency, intravenous injection, HIV infection, cocaine,
detoxification, AODD treatment unit, recommendations or guidelines,
human study |
Alecia D. Schweinsburg, Brian C. Schweinsburg, Erick H. Cheung, Gregory
G. Brown, Sandra A. Brown, and Susan F. Tapert. fMRI
response to spatial working memory in adolescents with comorbid
marijuana and alcohol use disorders. Drug and Alcohol Dependence 79(2):201-210, August 2005.
Address correspondence to Susan F. Tapert,
University of
California San Diego Department of Psychiatry, 9500 Gilman Dr., La
Jolla, CA 92037-0603, USA. stapert@ucsd.edu
Summary:
Although alcohol
and marijuana use are prevalent in adolescence, the neural impact
of their combined use remains unclear. The authors previously
demonstrated
functional magnetic resonance imaging (fMRI) response to spatial
working memory (SWM) among adolescents with alcohol use disorders (AUD)
compared to controls, and predicted that adolescents with marijuana and
alcohol use disorders would show additional abnormalities. Their
present study tested that prediction. Three groups of adolescents
(15–17 years old) participated: non-abusing controls (n = 19), AUD
with limited exposure to drugs (n
= 15), and comorbid
marijuana and alcohol use disorders (MAUD) and minimal other drug
experience (n =
15). After >2 days’ abstinence, participants
performed a SWM
task during fMRI acquisition. fMRI brain response patterns differed
between groups, despite similar performance on the task. MAUD youths
showed less activation in inferior frontal and temporal regions than
controls, and more response in other prefrontal regions. Compared to
AUD adolescencts, MAUD youths also showed less inferior frontal and
temporal
activation, but more medial frontal response. Overall, MAUD youths
showed different brain response abnormalities than those with AUD
alone, despite relatively short histories of substance involvement.
This pattern could suggest compensation for marijuana-related attention
and working memory deficits. However, relatively recent use and
premorbid features may influence results, and should be examined in
future studies.
NIAAA
Glossary Terms: marijuana in any form, illicit drug,
underage drinking, adolescence, magnetic resonance imaging, brain
imaging, alcohol use disorder classification, comorbidity, multiple
drug use, controlled study, comparative study, cerebral cortex,
frontal cortex,
attention,memory, human
study |
David M. Penetar, Elena M. Kouri, Michelle M. Gross, Elissa M.
McCarthy, Christina K. Rhee, Erica N. Peters, and Scott E. Lukas.
Transdermal
nicotine alters some of marihuana's effects in male and female
volunteers. Drug
and Alcohol Dependence 79(2):211-223,
August 2005.
Address correspondence to David M. Penetar,
Behavioral
Psychopharmacology Research Laboratory, McLean Hospital/Harvard Medical
School, 115 Mill Street, Belmont, MA 02478, USA. dpenetar@mclean.harvard.edu
Summary:
The effects of nicotine on marijuana-induced intoxication were
investigated in a double blind, crossover study using nicotine
transdermal patches. The participants (10 males and 10 females)
received
either placebo or a 21-mg transdermal nicotine patch 4 hours before
smoking
one of two marijuana cigarettes (1.99% or 3.51%
delta-9-tetrahydrocannabinol content). Measurements of physiological
activity -- heart rate, blood
pressure, and skin temperature -- and subjective effects --
self-reports of
drug effects on visual analog scales (VAS) and the Addiction Research
Center Inventory (ARCI) -- were made periodically before and for
3
hours
after smoking. Nicotine pretreatment enhanced several responses to
marijuana, in particular, heart rate, reports of "stimulated" on the
visual analog scales, and scores on the Amphetamine scale of the ARCI.
Compared to female participants, male participants reported a more
pronounced and longer-lasting effect of marijuana. Compared to the
male participants, female participants experienced an attenuated
response to marijuana and were less affected by the drug combination.
The results of this study show that nicotine can have an important
influence on the subjective and physiological effects of smoked
marijuana. These effects have safety and efficacy
implications for marijuana smokers who use the nicotine
transdermal patch to manage their tobacco dependence.
NIAAA
Glossary Terms: nicotine, marijuana in any form,
smoking, AOD intoxication, multiple drug use, heart rate, blood
pressure, temperature, gender differences, controlled study, human study
|
Ilsemarie Kurzthaler, Markus Wambacher, Karl Golser, Gernot Sperner,
Barbara Sperner-Unterweger, Alexander Haidekker, Marion Pavlic, Georg
Kemmler, and W. Wolfgang Fleischhacker. Alcohol and
benzodiazepines in falls: An epidemiological view. Drug and Alcohol Dependence 79(2):225-230, August 2005.
Address correspondence to Ilsemarie
Kurzthaler, Department of
Biological Psychiatry, Medical University Innsbruck, Anichstrasse 35,
A-6020 Innsbruck, Austria. ilsemarie.kurzthaler@uibk.ac.at
Summary:
Concentrations of blood alcohol (BAC) and benzodiazepines (BZD) were
studied in patients
attending an emergency department because of a fall over a 1-year
period. Of the 615
patients tested, 22% were positive for alcohol, 55% were positive for
BZD, and 1.5% were positive for both alcohol and BZD. A
significantly larger proportion of males tested positive for alcohol
than females (40.2% versus 7.6%). Both in males and females the
percentage
as well as the extent of blood alcohol levels decreased significantly
with age. Benzodiazepines were also consumed more frequently in males
(8.5%) than in females (3.2%, p
= 0.007). There was no
difference in BAC between males and females (1.75
± 0.81 g/l versus 1.66
± 0.91 g/l). In patients older than 70 years the BAC (1.30
± 0.80 g/l) was lower compared to younger patients. All
BZD-positive blood samples could be traced back to diazepam
consumption. A high number of young and middle aged patients
using alcohol was found (49.7% of males, 18.9% of females); a lower but
still
relevant number of benzodiazepine users was also found (9.5% of males,
2.4% of females). The study shows that alcohol plays a more important
role
in fall-related accidents in patients up to 70 years old when compared
to
accidents from other causes.
NIAAA
Glossary Terms:
accidental fall, injury, BAC, benzodiazepines, diazepam, emergency
care, multiple drug use, prevalence, gender differences, age
differences, human study
|
Fabian Termorshuizen, Anneke Krol, Maria Prins, Ronald Geskus, Wim van
den Brink, and Erik J.C. van Ameijden. Prediction
of relapse to frequent heroin use and the role of methadone
prescription: An analysis of the Amsterdam Cohort Study among drug users.
Drug and
Alcohol Dependence 79(2):231-240,
August 2005.
Address correspondence to Fabian
Termorshuizen, Municipal Health
Service, Amsterdam, Cluster Infectious Diseases, Department of HIV
& STI Research, Nieuwe Achtergracht 100, 1018 WT Amsterdam, The
Netherlands. ftermorshuizen@gggd.amsterdam.nl
Summary:
The
risk of relapse into frequent heroin use was studied among participants
(N = 732) in the Amsterdam
Cohort Study (ACS) on human immunodeficiency virus/acquired
immunodeficiency syndrome (HIV/AIDS) among drug
users, who experienced an episode of abstinence from or occasional use
of heroin. The participants were recruited mainly from easy
access ("low-threshold") methadone programs. The duration of
abstinence/occasional use and relative risks (RR) of relapse were
estimated by survival analysis
of 1,577 episodes, using patient's characteristics and methadone
treatment as
covariates. The majority of episodes (85.8%) were followed by relapse
within 5 years. Less education, intense use of heroin prior to the
episode of abstinence or well-controlled use, occasional use of heroin
and intense use of cocaine during the episode, and having a drug-using
partner or having no partner were significantly associated with higher
risk of relapse. Among frequent attendees of a "low-threshold"
methadone program, relapse was associated with the daily dose of
methadone: RR for dosages <40 and 40–60 mg, compared with doses of
>100 mg, were 1.45 (p <
0.01) and 1.59 (p < 0.01)
respectively. There was no evidence of a beneficial influence of
methadone dosage
or program attendance per se
on the risk of relapse into cocaine.
High doses of methadone in a harm-reduction setting extend the duration
of an episode of no or occasional use of heroin. Other factors, such as
no occasional use of heroin during the episode, no use of cocaine, and
having a non-using partner, seem to be equally important.
NIAAA
Glossary Terms: heroin, AOD user, AOD dependence, AOD
use pattern, AOD abstinence, methadone, AODD relapse, HIV infection,
acquired immunodeficiency syndrome, risk factors, risk analysis,
relative risk, cocaine, human study
|
Tracy L. Simpson, Daniel R. Kivlahan, Kristen R. Bush, and Miles E.
McFall. Telephone
self-monitoring among alcohol use disorder patients in early recovery:
A randomized study of feasibility and measurement reactivity.
Drug and
Alcohol Dependence 79(2):241-250,
August 2005.
Address correspondence to Tracy L. Simpson, VA
Puget Sound
Health Care System, Seattle, WA 98108, USA. tracy.simpson@med.va.gov
Summary:
This pilot study with patients in early recovery from an
alcohol use disorder evaluated compliance with two Interactive
Voice Response (IVR)
monitoring protocols, subjective experiences with monitoring, and
change in symptoms associated with monitoring (i.e., measurement
reactivity). Participants (n = 98) were
randomly assigned to call an IVR system
daily for 28 days, once per week for 4 weeks, or only to complete
28-day follow-up assessment including retrospective drinking reports.
Monitoring calls assessed alcohol craving, substance use, emotional
well-being, and post-traumatic stress disorder (PTSD) symptoms. Most
monitoring participants completed
calls on at least 75% of scheduled days (72.2% and 59.2% for daily and
weekly respectively). Including reconstructed data from follow-up of
missed calls yielded 77.8% and 74.1% of maximum data points
respectively. Most monitoring participants indicated the protocol was
manageable and reported positive or no effects of monitoring on urges
to use alcohol, actual drinking, and PTSD symptoms. Analyses of
measurement reactivity based on assessment 1 month after
randomization found no significant group differences on drinking,
craving for alcohol, or PTSD-related symptoms. The results suggest that
IVR
technology is feasible and appropriate for telephone symptom monitoring
in similar clinical samples.
NIAAA
Glossary Terms: AOD
abuse, AOD dependence,
pilot study, patient compliance, patient monitoring, patient
assessment, AOD craving, AOD use,
emotional adjustment,
posttraumatic stress disorder, human study |
Evgeny M. Krupitsky, Nicholas J. Horton, Emily C. Williams, Dmitri
Lioznov, Maria Kuznetsova, Edwin Zvartau, and Jeffrey H. Samet. Alcohol use
and HIV risk behaviors among HIV-infected hospitalized patients in St.
Petersburg, Russia. Drug and Alcohol Dependence 79(2):251-256, August 2005.
Address correspondence to Jeffrey H. Samet,
Department of Social
and Behavioral Sciences, Boston University School of Public Health, 91
East Concord Street, Suite 200, Boston, MA 02118, USA. jsamet@bu.edu
Summary:
Although Russia has high per capita alcohol consumption and an epidemic
of human immunodeficiency virus (HIV) infection driven by injection
drug use, the
role of alcohol in
the spread of HIV in the country is largely unexplored. This
study
assessed recent alcohol use and associated HIV risk behaviors among
HIV-infected persons in St. Petersburg, Russia. HIV-infected
hospitalized patients were recruited from an infectious disease
hospital between June 2001 and March 2002. Interviewers assessed
alcohol and drug use, and lifetime abuse or dependence diagnoses for
alcohol and drugs were
established by a physician with addiction medicine training. Among the
subjects (N = 201), diagnoses
of abuse or dependence (Ab/Dep) were
common: 9% had only alcohol Ab/Dep; 39%
had alcohol
and drug Ab/Dep; 47% had only drug Ab/Dep;
and 4% had
no diagnosis of alcohol or drug Ab/Dep.
Sex- and drug-risk behaviors
varied significantly by substance use diagnosis. Subjects with any
alcohol Ab/Dep had higher sex-risk
scores than those with drug only Ab/Dep
(6.1 versus 3.9, p <
.0001). Among subjects with any
diagnosis of drug Ab/Dep, having in
addition an alcohol diagnosis was
associated with unclean needle use in the last 6 months (33% versus
21%, p = 0.08). In
conclusion, lifetime alcohol diagnoses
of abuse or dependence were present in nearly -half of hospitalized
HIV-infected patients in St. Petersburg and were associated
with significantly higher sex-risk behaviors and borderline
significantly higher drug-risk behaviors. As HIV infection spreads
rapidly in Russia and Eastern Europe, these data support the need for
HIV risk-reduction interventions in alcohol abusing populations and
raise the potential of benefit by addressing alcohol use in
HIV-infected populations.
NIAAA
Glossary Terms:
Russia, AOD consumption, AOD abuse, AOD dependence, HIV infection,
risk-taking behavior, sexual behavior, intravenous injection,
patient
assessment, prevalence, human study
|
Suzanne K. Vosburg, Carl L. Hart, Margaret Haney, and Richard W.
Foltin. An
evaluation of the reinforcing effects of memantine in cocaine-dependent
humans. Drug
and Alcohol Dependence 79(2):257-260,
August 2005.
Address correspondence to Suzanne K. Vosburg,
College of
Physicians and Surgeons of Columbia University, New York State
Psychiatric Institute, New York, NY 10032, USA. skv2001@columbia.edu
Summary:
The
reinforcing and subjective effects of the uncompetitive
N-methyl-D-aspartate (NMDA) antagonist memantine was
evaluated in a double-blind, outpatient study of cocaine-dependent
individuals (N = 8; 2 females,
6 males). The
study consisted of three blocks of seven sessions, with each block
testing a different dose of memantine. During the first two sessions of
each block, participants "sampled" the memantine capsule (10, 20, or 30
mg) and the placebo capsule that were available for the next five
sessions. During the five subsequent sessions, participants had an
opportunity to self-administer either the active or placebo capsule.
Memantine was not reinforcing and subjective-effects ratings were not
altered as a function of dose. The results suggest that these doses of
memantine do not have abuse liability in cocaine-dependent individuals.
NIAAA
Glossary Terms: antagonists,
N methyl D aspartate, reinforcement,
subjective variables,
double-blind study, controlled study, cocaine, AOD dependence,
AOD abuse potential, human study |
Brice M.R. Appenzeller, Serge Schneider, Armand Maul, and Robert
Wennig. Relationship
between blood alcohol concentration and carbohydrate-deficient
transferrin among drivers. Drug
and Alcohol Dependence 79(2):261-265,
August 2005.
Address correspondence to Brice M.R.
Appenzeller, Centre de
Recherche Public de la Santé, Laboratoire National de
Santé, Division de Toxicologie, Université du Luxembourg,
Campus Limpertsberg, 162a, avenue de la Faïencerie, L-1511
Luxembourg. brice.appenzeller@cu.lu
Summary:
Carbohydrate-deficient
transferrin (CDT) was measured in 408 blood specimens, randomly
selected from drivers (N =
1,260) apprehended and submitted to blood alcohol
concentration (BAC) determination. The first step of the study was to
observe whether a BAC-based pre-evaluation was relevant for deciding to
test drivers for chronic alcohol abuse. For this purpose, the diagnosis
of chronic alcohol abuse was verified by CDT determination, with a
high positive cut-off selected at 3% for high specificity. The
results showed a significant increase in the part of chronic alcohol
abusers with respect to increasing BAC: a few alcohol abusers were
present in the BAC category below 0.5 g/L, and their frequency
increased to 47% when BAC was between 3 and 3.5 g/L and
67% when BAC was above
3.5 g/L. Secondly, the usefulness of the biomarker CDT in
the traffic safety context was investigated by observing whether
drivers with abnormally increased CDT value had also higher BAC. The
average BAC was 1.32 g/L in drivers with CDT below 1%, and increased to
2.28 g/L in drivers with CDT above 3%. Statistical analysis showed
evidence of a monotonic increasing link between BAC and CDT (p <
0.0001). The results confirm the relevance of BAC-based pre-evaluation
before testing chronic alcohol abuse among drivers, and demonstrate
that CDT is a suitable biomarker in the context of traffic safety, as
drivers
with increased CDT had significantly higher BAC.
NIAAA
Glossary Terms: carbohydrate-deficient
transferrin,
BAC level, chronic AODE, prevalence, AODR biological markers,
highway safety, statistical association, human study |
Marilyn W. Lewis and Nancy M. Petry. Contingency
management treatments that reinforce completion of goal-related
activities: Participation in family activities and its association with
outcomes. Drug
and Alcohol Dependence 79(2):267-271,
August 2005.
Address correspondence to Nancy M. Petry,
School of Medicine,
Department of Psychiatry, University of Connecticut
Health Center, 263 Farmington Avenue, Farmington, CT 06030-3944, USA. petry@psychiatry.uchc.edu
Summary:
Although contingency
management (CM) techniques that reinforce completion of nondrug related
activities may be effective in treating substance dependence, no
studies have evaluated whether involvement in particular kinds
of activities reduces problems associated with those activities. In
this
study, cocaine-abusing adults (N
= 159) who had been randomized to a CM intervention
were classsified according to whether they engaged (n = 29) or did not engage (n = 130) in three or more
family-related activities during the 12-week treatment period.
The groups were evaluated for differences in treatment
retention, length of continuous abstinence, and changes from baseline
to the end of the intervention in Addiction
Severity Index-family scores and days of family
conflict. Participants who engaged in family activities remained in
treatment longer, were abstinent for more weeks, and
reported greater reduction in family conflict compared to participants
who did not engage in family activities. The results suggest
that participants who elect to complete family related activities
during CM treatments may have improved outcomes and reduced family
conflict.
NIAAA
Glossary Terms: contingency
management, AOD abuse, cocaine,
patient retention,
AOD abstinence, psychiatric status rating scales, family relations,
family conflict, human study |
John R. Monterosso, Adam R. Aron, Xochitl Cordova, Jiansong Xu, and
Edythe D. London. Deficits in
response inhibition associated with chronic methamphetamine abuse.
Drug and
Alcohol Dependence 79(2):273-277,
August 2005.
Address correspondence to John R. Monterosso,
Department of
Psychiatry and Biobehavioral Sciences, University of California Los
Angeles, Los Angeles, CA 90024-1759, USA. jmont@ucla.edu
Summary:
Chronic
methamphetamine abuse is associated with cerebral deficits
involving frontal/basal-ganglia regions that are important for
inhibitory control. Using the Stop-Signal Task, this study measured
response
inhibition in 11 methamphetamine abusers
(5–7 days abstinent) and two groups of
control subjects who did not use methamphetamine
(14 tobacco smokers and 29
non-smokers). Stop-signal reaction time (SSRT), which indicates the
latency to inhibit an initiated motor response, was significantly
longer for methamphetamine abusers than
for either control group (p
values < 0.01). In
contrast, the methamphetamine abusers
did not differ from either group on Go trial
reaction time (RT), which reflects motor speed, or number of
discrimination errors, which reflects decision-processes. Methamphetamine
abuse was therefore associated with a specific deficit in inhibiting a
pre-potent response. The authors suggest that future research could
examine whether SSRT is
different for methamphetamine abusers
who respond to treatment compared to those who
do not. If such differences are established, response inhibition
may serve as a marker for investigating methamphetamine
abuse in basic research and
clinical trials.
NIAAA
Glossary Terms:
methamphetamine, AOD abuse, cerebrum, inhibition,
disinhibition,
reaction time,
decision making, AODR behavioral markers, human study |
Home Page
Drug
and Alcohol Dependence
Volume
79, Number 1, July 2005
(Updated 6/29/2005)
Home Page
Hendree
E. Jones, Rolley E. Johnson, Donald R. Jasinski, Kevin E.
O’Grady, Christian A. Chisholm, Robin E. Choo, Michael Crocetti, Robert
Dudas, Cheryl Harrow, Marilyn A. Huestis, Lauren M. Jansson, Michael
Lantz, Barry M. Lester, and Lorraine Milio. Buprenorphine
versus methadone in the treatment of pregnant opioid-dependent
patients: Effects on the neonatal abstinence syndrome.
Drug and Alcohol
Dependence 79(1):1-10,
July 2005.
Summary:
The neonatal abstinence syndrome (NAS) was compared in
neonates of opioid-dependent women maintained on methadone or
buprenorphine during pregnancy. The study was a randomized,
double-blind,
double-dummy, flexible dosing, parallel-group controlled trial
conducted in a comprehensive drug-treatment facility that included
residential and ambulatory care. Preliminary
safety and efficacy
data were also obtained for a larger multi-center trial. Treatment
involved daily flexible
dosing with either sublingual buprenorphine (4–24 mg)
or oral methadone (20–100 mg). Primary
outcome measures were: (1) number of neonates treated for NAS;
(2) amount of opioid agonist medication used to treat NAS; (3) length
of neonatal hospitalization; and (4) peak NAS score. Two of 10 (20%)
buprenorphine-exposed and 5 of 11 (45.5%) methadone-exposed neonates
were treated for NAS (p
= 0.23). Methadone-exposed neonates required
three times more total opioid-agonist medication to treat their NAS
than buprenorphine-exposed neonates (93.1
versus 23.6; p =
0.13). Length of hospitalization was shorter for
buprenorphine-exposed than for methadone-exposed neonates (p = 0.021).
The two groups did not differ significantly in peak NAS total scores (p =
0.25). These findings suggest that buprenorphine is not inferior to
methadone
on outcome measures assessing NAS and maternal and neonatal safety when
administered starting in the second trimester of pregnancy.
NIAAA
Glossary Terms:
AODR neonatal disorder, AOD withdrawal syndrome, AOD dependence,
buprenorphine, mother,
prenatal chemical exposure, prenatal care, drug therapy, methadone, buprenorphine,
opioids, addiction, clinical study, controlled study, comparative
study, agonists, hospital, length of stay, second trimester, human study
|
Chuan-Yu Chen, Megan S. O’Brien, and James C. Anthony. Who becomes
cannabis dependent soon after onset of use? Epidemiological evidence
from the United States: 2000–2001. Drug and Alcohol Dependence 79(1):11-22, July 2005.
Summary:
The aims were to estimate the risk of becoming cannabis dependent
within
24 months after first use of cannabis and to examine subgroup variation
in
this risk. The estimates were based on the National Household
Survey on Drug Abuse conducted during 2000–2001 with a
representative
sample of U.S. residents ages 12 and older (N = 114,241). First-time use
of cannabis within the 24 months prior to assessment was found in 3,352
respondents. An estimated 3.9%
of these recent-onset users developed a cannabis dependence syndrome
during the interval since first use. Excess risk of cannabis
dependence was found
for those with cannabis onset before late adolescence, those with
family income under US$ 20,000, and those who had used three or
more drugs before the first use of cannabis (i.e., tobacco, alcohol,
and other drugs). While these findings generally support previous
results, the study's focus on recent-onset users, thus removing
the influence of users with long-sustained or persistent
cannabis dependence developed years ago, more closely
approximates prospective and longitudinal research on the risk of
becoming cannabis dependent soon after onset of cannabis use.
NIAAA
Glossary Terms: AOD dependence, risk analysis, risk
factors, marijuana in any form, household survey,
recent onset of AOD use, early
AODU onset, adolescence,
income effect, multiple drug use, human study |
Elizabeth R. Disney, Michael Kidorf, Van L. King, Karin Neufeld, Ken
Kolodner, and Robert K. Brooner. Prevalence
and correlates of cocaine physical dependence subtypes using the DSM-IV
in outpatients receiving opioid agonist medication. Drug and Alcohol Dependence 79(1):23-32, July 2005.
Summary:
The relationship
between endorsement of physiological dependence to cocaine and lifetime
and current problem severity was examined in a cross-sectional study of
opioid and cocaine dependent
individuals newly admitted to a treatment program based on
opioid-agonist
medication. All participants (N
= 719) completed the structured clinical
interview for the Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV)
(SCID-IV)
and the Addiction Severity Index
(ASI). Participants were first
classified into physiological (n
= 549) versus non-physiological (n
=
170) cocaine dependence groups for one set of analyses and then
categorized into one of four groups for further analyses: (1) tolerance
only (n = 215), (2) tolerance
plus withdrawal (n = 279), (3)
withdrawal
only (n = 55), or (4) no
physiological dependence (n =
170). The
participants who endorsed physiological dependence reported higher
rates of lifetime psychiatric and substance use disorders, higher rates
of current drug use, and more current problems. The four-group analyses
showed that endorsement of withdrawal, with or without tolerance, was
associated with the most severe problems. The results suggest that
physiological dependence to cocaine (particularly th | | |